FDA Safety Update: Dermal Fillers and Risks of Delayed Inflammation
The U.S. Food and Drug Administration (FDA) recently updated both its web page on Dermal Fillers (Soft Tissue Fillers) and on Dermal Fillers Do’s and Don’t for Wrinkles, Lips and More. A spokesperson for the FDA reported that the update was made in response to postmarketing data from the FDA’s adverse event—reporting databases, including the Manufacturer and User Facility Device Experience (MAUDE) for devices and the Vaccine Adverse Event Reporting System (VAERS) for vaccines, published literature and recommendations from federal agencies and professional societies.
“More specifically, the site was updated to include certain risks of using dermal fillers such as swelling and bruising as well as some less common risks such as inflammation—swelling or redness near the dermal filler injection site—following viral or bacterial illnesses or infections, vaccinations, or dental procedures,” the spokesperson said.